News

The phase IIb trial will be conducted at 30 sites in the US, where 1,000 potential subjects are being recruited. “Given the remarkable safety profile of NB-001 and

The vaccines were found to stabilize CD4+ T-cell counts compared with placebo in HIV patients who have not started antiretroviral therapy. The data are from a year-long safety

Over the last several years, an increasing body of evidence points to dysfunctional copper homeostasis in the pathogenesis of Alzheimer's. Recently, a published study demonstrated that consuming a

The study was led by a team at the National Institute of Allergy and Infectious Diseases. The HIV virus has numerous levels of defense but this protein component

The studies demonstrated that GRN163L induces altered tumor cell adhesion in animal models and that it may have additional benefit in the prevention of metastasis. Previous studies demonstrated

The AIDS Healthcare Foundation (AHF) has moved to petition the FDA due to what it believes are questionable marketing tactics for Viagra, which encourages the recreational use of

MCT-475 is indicated as a prospective treatment for metastatic colorectal cancer which is intended to be co-administered with MCT-465, a Toll-like Receptor (TLR) agonist. “Previously we demonstrated that

The price of the 600mg formulation of Stocrin has been reduced by 14.5% to $0.65 per day, or $237.25 per patient per year from $0.76 per day, for

Its primary objective is to demonstrate the safety of Light Infusion Therapy (Litx) with increasing light doses in the treatment of primary or recurrent glioma, including glioblastoma and